LVE:PA:PA-Lyxor UCITS Stoxx 50 Daily Leverage (EUR)

ETF | Others |

Last Closing

USD 52.97

Change

0.00 (0.00)%

Market Cap

USD 0.12B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.11 (+0.24%)

USD 64.67B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-2.25 (-0.46%)

USD 10.34B
WRD:PA HSBC ETFs Public Limited Compa..

-0.11 (-0.35%)

USD 9.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.22 (-0.09%)

USD 7.53B
HHH:PA HSBC ETFs Public Limited Compa..

-0.23 (-0.46%)

USD 6.65B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-2.00 (-0.48%)

USD 6.61B
WLD:PA Lyxor UCITS MSCI World D-EUR

-1.01 (-0.32%)

USD 6.26B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.06 (-0.36%)

USD 4.96B
500U:PA Amundi Index Solutions - Amund..

-0.60 (-0.58%)

USD 4.44B
WSRI:PA Amundi MSCI World SRI Climate ..

-0.34 (-0.36%)

USD 4.01B

ETFs Containing LVE:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.32% 93% A 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.32% 93% A 89% A-
Trailing 12 Months  
Capital Gain 27.96% 83% B 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.96% 81% B- 83% B
Trailing 5 Years  
Capital Gain 106.27% 97% N/A 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 106.27% 97% N/A 92% A
Average Annual (5 Year Horizon)  
Capital Gain 19.40% 92% A 85% B
Dividend Return 19.40% 95% A 85% B
Total Return N/A 62% D 78% C+
Risk Return Profile  
Volatility (Standard Deviation) 37.62% 57% F 26% F
Risk Adjusted Return 51.58% 77% C+ 70% C-
Market Capitalization 0.12B 35% F 48% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.